The combined effect of interferon beta and radiation on five human tumor cell lines and embryonal lung fibroblasts

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 2, 1999, Pages 405-412

  Schmidberger, Heinz ^a   Rave Fr̈ank, Margret ^a   Lehmann, J̈org ^a   Schweinfurth, Simone ^a   Rehring, Erika ^a   Henckel, Karin ^a   Hess, Clemens F ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cell lines; Cytokines; In vitro; Interferon; Radiation; Radiosensitization

Indexed keywords

BETA INTERFERON;

ARTICLE; BREAST CARCINOMA; CANCER CELL; COLON CARCINOMA; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG CARCINOMA; LUNG FIBROBLAST; PRIORITY JOURNAL; RADIOSENSITIZATION; UTERINE CERVIX CARCINOMA;

HUMANS; INTERFERON-BETA; NEOPLASMS; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0033556690     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00411-8     Document Type: Article

References (23)

1. Borden E.S. Interferons as biochemical modulators. Editorial. J Clin Oncol. 14:1996;2627-2630.
2. Borden E.C. Progress toward therapeutic application of interferons, 1979-1983. Cancer. 54:1984;2770-2776.
3. Lokshin A.S., Mayotte J.E., Levitt M.L. Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J Natl Cancer Inst. 87:1995;206-212.
4. Angioli R., Sevin B.-U., Perras J.D., et al. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines. Cancer. 71:1993;3717-3725.
5. Angioli R., Sevin B.-U., Perras J.D., et al. Rationale of combining radiation and interferon for the treatment of cervical cancer. Oncology. 49:1992;445-449.
6. Byhardt R.W., Vaickus L., Witt P.L., et al. Recombinant human Interferon-β (rHuIFN-β) and radiation therapy for inoperable non-small cell lung cancer. J Interferon Cytokine Res. 16:1996;891-902.
7. Chang A.Y.C., Keng P.C. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. Cancer Res. 47:1987;4338-4341.
8. Dritschilo A., Mossmann K., Gray M., Sreevalsan T. Potentiation of radiation injury by interferon. Am J Clin Oncol. 5:1982;79-82.
9. Gould M.N., Kakria R.C., Olson S., Borden E.C. Radiosensitization of human bronchogenic carcinoma cells by interferon beta. J Interferon Res. 4:1984;123-128.
10. McDonald S., Chang A., Rubin P., et al. Combined betaseron r (recombinant interferon beta) and radiation for inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 27:1993;613-619.
11. McDonald S., Rubin P., Chang A., Penney D., Finkelstein J., Grossberg S., Gregory P. Pulmonary changes induced by combined mouse b-interferon and radiation in normal mice - toxic versus protective effects. Radiother Oncol. 26:1993;212-218.
12. Mertens R., Granzen B., Gademann G., Hess C.F., Heimann G. Nasopharyngeal carcinoma in childhood and adolescence. Concept and preliminary results of the cooperative GPOH study NPC-91. Cancer. 80:1997;951-959.
13. Namba M., Yamamoto S., Tanaka H., Kanamori T., Nobuhara M., Kimoto T. In vitro studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma ray by interferon on human neoplastic cells. Cancer. 54:1984;2262-2267.
14. Busch M., Rave-Fränk M., Franke T., Dühmke E. Effect of combined natural human beta-interferon and radiation on human tumor cells. Onkologie. 19:1996;501-504.
15. Byhardt R.W. Can interferon beta make for the radiation therapy team for the treatment of non-small cell lung cancer? Int J Radiat Oncol Biol Phys. 27:1993;753-756.
16. Rave-Fränk M., Virsik-Peukert P., Bertram K., Schmidberger H. Chromosome analysis in primary cells of human squamous cell carcinoma by fluorescence in situ hybridization. Int J Radiat Biol. 69:1996;695-700.
17. Haddock M.G., Ames M.M., Bonner J.A. Assessing the interaction of irradiation with etoposide or idarubicin. Mayo Clin Proc. 70:1995;1053-1060.
18. Steel G.G. Terminology in the description of drug-radiation interactions. Int J Radiat Oncol Biol Phys. 5:1979;1145-1150.
19. Wasserman T.H., Chapman J.D., Coleman C.N. Chemical modifiers of radiation. Perez C.A., Brady L.W. Principles and practice of radiation oncology. 3rd ed. 1997;685-704 Lippincott-Raven, Philadelphia, PA.
20. Packer R.J., Prados M., Phillips P., et al. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant β-Interferon and hyperfractionated radiation therapy. Cancer. 77:1996;2150-2156.
21. Kelly J.M., Gilbert C.S., Stark G.R., et al. Differential regulation of interferon-induced mRNAs and c-myc mRNA by alpha- and gamma-interferons. Eur J Biochem. 153:1985;367-371.
22. Osanto S., Jansen R., Vloemans M., et al. Down-modulation of c-myc expression by interferon gamma and tumor necrosis factor alpha precedes growth arrest in human melanoma cells. Eur J Cancer. 28A:1992;1622-1627.
23. Platanias L.C. Interferons laboratory to clinic investigations . Curr Opin Oncol. 7:1995;560-565.